Harraden Discloses 8.11% Stake in ARC Group Acquisition I
ARC Group Acquisition I Corp. reports a Schedule 13G disclosing beneficial ownership of 1,035,000 Class A shares by Harraden-related entities, representing 8.11% of the Class A outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ARC Group Acquisition I Corp. reports a Schedule 13G disclosing beneficial ownership of 1,035,000 Class A shares by Harraden-related entities, representing 8.11% of the Class A outstanding.
The filing states that the reported shares are directly owned by Harraden Circle Investors, LP and related limited partnerships, with shared voting and dispositive power of 1,035,000 shares. The disclosure notes the reporting chain: Harraden GP is general partner, Harraden LLC is general partner of the GP, Harraden Adviser manages the funds, and Frederick V. Fortmiller, Jr. is managing member.
Insights
Harraden entities report an 8.11% passive stake in ARC Group Acquisition I Corp.
The Schedule 13G lists 1,035,000 Class A shares as beneficially owned by Harraden-linked funds with shared voting and dispositive power. The filing identifies the ownership chain through Harraden GP and Harraden LLC and names Frederick V. Fortmiller, Jr. as managing member.
Future SEC filings may show changes in ownership; this filing is a disclosure of current holdings and classifies the position under the Schedule 13G reporting standard.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Harraden report in ARC Group Acquisition I Corp. (ARCLU)?
Who is the ultimate reporting person for the 13G filing for ARCLU?
What class and CUSIP are referenced in the Harraden 13G for ARCLU?
AI-generated analysis. How Rhea-AI works. Not financial advice.